AI assistant
Arcadia Biosciences, Inc. — Director's Dealing 2016
Apr 28, 2016
35424_dirs_2016-04-27_246c5bd2-ddd5-4931-a89a-9bbce14410ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-04-25
Reporting Person: Brandwein Steven F. (Interim Chief Financ. Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-25 | Common Stock | S | 1720 | $2.424 | Disposed | 9030 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 39965 | Indirect |
Footnotes
F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective December 11, 2015, as amended March 14, 2016.
F2: This transaction was executed in multiple trades at prices ranging from $2.40 to $2.45. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Includes 750 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 1, 2016.